494 related articles for article (PubMed ID: 24267244)
1. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
[TBL] [Abstract][Full Text] [Related]
2. Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris.
Li HL; Peng WH; Cui ST; Lei H; Wei YD; Li WM; Xu YW
Clin Chem Lab Med; 2011 Sep; 49(9):1547-54. PubMed ID: 21913793
[TBL] [Abstract][Full Text] [Related]
3. Increased expression and plasma levels of myeloperoxidase are closely related to the presence of angiographically-detected complex lesion morphology in unstable angina.
Naruko T; Furukawa A; Yunoki K; Komatsu R; Nakagawa M; Matsumura Y; Shirai N; Sugioka K; Takagi M; Hozumi T; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
Heart; 2010 Nov; 96(21):1716-22. PubMed ID: 20956487
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
Jornayvaz FR; Brulhart-Meynet MC; James RW
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):613-9. PubMed ID: 19201174
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum neopterin levels and coronary heart disease.
Liu ZY; Li YD
Genet Mol Res; 2013 Oct; 12(4):4222-9. PubMed ID: 24114217
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis.
Güray U; Erbay AR; Güray Y; Yilmaz MB; Boyaci AA; Sasmaz H; Korkmaz S; Kütük E
Int J Cardiol; 2004 Aug; 96(2):235-40. PubMed ID: 15262039
[TBL] [Abstract][Full Text] [Related]
7. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
8. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
[TBL] [Abstract][Full Text] [Related]
9. The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome.
Akçay AB; Camsarı A; Ozcan T; Ciçek D; Akkuş N; Seyis S; Cimen B; Celebi B; Döven O; Cin G
Turk Kardiyol Dern Ars; 2011 Jul; 39(5):371-7. PubMed ID: 21743260
[TBL] [Abstract][Full Text] [Related]
10. Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina.
Tretjakovs P; Jurka A; Bormane I; Mikelsone I; Elksne K; Krievina G; Reihmane D; Verbovenko J; Bahs G
Clin Chim Acta; 2012 Jan; 413(1-2):25-9. PubMed ID: 22024218
[TBL] [Abstract][Full Text] [Related]
11. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
12. Association of paraoxonase activity and coronary blood flow.
Yildiz A; Gur M; Yilmaz R; Demirbag R; Polat M; Selek S; Celik H; Erel O
Atherosclerosis; 2008 Mar; 197(1):257-63. PubMed ID: 17537444
[TBL] [Abstract][Full Text] [Related]
13. Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
Sentürk T; Sarandöl E; Güllülü S; Erdinç S; Ozdemir B; Baran I; Aydinlar A
Acta Cardiol; 2008 Jun; 63(3):361-7. PubMed ID: 18664028
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.
Dullaart RP; Otvos JD; James RW
Clin Biochem; 2014 Aug; 47(12):1022-7. PubMed ID: 24769273
[TBL] [Abstract][Full Text] [Related]
15. Characterization of interleukin-33 and matrix metalloproteinase-28 in serum and their association with disease severity in patients with coronary heart disease.
Liu CL; Shen DL; Zhu K; Tang JN; Wang XF; Zhang L; Zhang JY
Coron Artery Dis; 2014 Sep; 25(6):498-504. PubMed ID: 24710352
[TBL] [Abstract][Full Text] [Related]
16. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
[TBL] [Abstract][Full Text] [Related]
17. Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
Emami Razavi A; Basati G; Varshosaz J; Abdi S
Acta Med Iran; 2013 Jul; 51(6):365-71. PubMed ID: 23852840
[TBL] [Abstract][Full Text] [Related]
18. Plasma pre beta1-HDL level is elevated in unstable angina pectoris.
Tashiro J; Miyazaki O; Nakamura Y; Miyazaki A; Fukamachi I; Bujo H; Saito Y
Atherosclerosis; 2009 Jun; 204(2):595-600. PubMed ID: 19054517
[TBL] [Abstract][Full Text] [Related]
19. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
[TBL] [Abstract][Full Text] [Related]
20. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
